Brennan, M., Weroha, S. J., Hou, X., Kaufmann, S. H., Dowdy, S. C., Glaser, G., Xu, C. (2025). Evaluating pegylated SN38 (PLX38A) and rucaparib in
            <i>TP53</i>
            wild-type endometrial cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e15125